Skip to main content

Peer Review reports

From: Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy

Original Submission
18 Jul 2023 Submitted Original manuscript
10 Dec 2023 Reviewed Reviewer Report - Daniele Marinelli
25 Jan 2024 Reviewed Reviewer Report
14 Feb 2024 Author responded Author comments - Jianzhen Shan
Resubmission - Version 2
14 Feb 2024 Submitted Manuscript version 2
11 Mar 2024 Reviewed Reviewer Report - Daniele Marinelli
15 Apr 2024 Author responded Author comments - Jianzhen Shan
Resubmission - Version 3
15 Apr 2024 Submitted Manuscript version 3
28 Apr 2024 Reviewed Reviewer Report - Daniele Marinelli
19 May 2024 Author responded Author comments - Jianzhen Shan
Resubmission - Version 4
19 May 2024 Submitted Manuscript version 4
23 May 2024 Author responded Author comments - Jianzhen Shan
Resubmission - Version 5
23 May 2024 Submitted Manuscript version 5
Publishing
30 May 2024 Editorially accepted
10 Jun 2024 Article published 10.1186/s12916-024-03462-4

You can find further information about peer review here.

Back to article page